ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

Intellia Therapeutics, Inc. Complete list of announcements declared & dividend announcements by Intellia Therapeutics, Inc. NTLA

Intellia Therapeutics, Inc. NTLA listed on USA and deals in Health Care Biotechnology In Vitro In Vivo Diagnostic Substances

Announcements and dividends declared by Intellia Therapeutics, Inc. NTLA

BMO Capital Upgrades Intellia Therapeutics (NTLA)
On March 14, 2023, BMO Capital upgraded their outlook for Intellia Therapeutics (NASDAQ:NTLA) from Market Perform to Outperform.
Announcement as on 15 March 2023

Will Intellia Therapeutics Stock Rebound After A 31% Fall In A Month?
Intellia Therapeutic’s stock (NASDAQ: NTLA), a biotechnology company developing treatments using the CRISPR gene-editing system, has seen a fall of 31% in a month, while it’s down 69% this year. This compares with -2% and -18% returns for
Announcement as on 20 December 2022

Is A Rise Imminent For Intellia Therapeutics Stock After 30% Fall In A Month?
The stock price of Intellia Therapeutics (NASDAQ: NTLA), a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the last week. This can be attributed to the U.S
Announcement as on 09 March 2022

Intellia Therapeutics Reaches Analyst Target Price
In recent trading, shares of Intellia Therapeutics Inc (Symbol: NTLA) have crossed above the average analyst 12-month target price of 5.00, changing hands for 8.07/share. When a stock reaches the target an analyst has set, the analyst logically has
Announcement as on 24 August 2021

Intellia Therapeutics Reaches Analyst Target Price
In recent trading, shares of Intellia Therapeutics Inc (Symbol: NTLA) have crossed above the average analyst 12-month target price of 5.00, changing hands for 8.07/share. When a stock reaches the target an analyst has set, the analyst logically has
Announcement as on 24 August 2021

Announcements by Intellia Therapeutics, Inc. first page | Next page | Prev page |

NTLA Intellia Therapeutics, Inc. current price & indicator signals

Moving Averages for Intellia Therapeutics, Inc.

  • 5Day Average: 13.42
  • 12Day Average: 11.93
  • 20Day Average: 10.87
  • 50Day Average: 9.73
  • 100Day Average: 13.46
  • 150Day Average: 12.71
  • 200Day Average: 11.55

NTLA Indicators & signals

Indicator MACD (12,26,9)

12.36, 11.25, 0.53
Indicator MACD is in positive zone

Indicator ADX (14)

70.83, 41.84, 7.14
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 59
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NTLA Intellia Therapeutics, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Thu Jan 2026 15.91 13.76 to 15.94 13.56% 1.42 times
21 Wed Jan 2026 14.01 12.94 to 14.49 9.28% 1.32 times
20 Tue Jan 2026 12.82 11.56 to 13.17 2.72% 1.34 times
16 Fri Jan 2026 12.48 11.70 to 12.75 4.87% 0.78 times
15 Thu Jan 2026 11.90 11.34 to 12.35 -0.92% 0.71 times
14 Wed Jan 2026 12.01 11.66 to 12.34 2.47% 0.73 times
13 Tue Jan 2026 11.72 11.20 to 12.29 2.36% 1.11 times
12 Mon Jan 2026 11.45 10.15 to 11.45 10.31% 1.01 times
09 Fri Jan 2026 10.38 10.13 to 10.98 -1.52% 1.23 times
08 Thu Jan 2026 10.54 10.32 to 10.83 4.05% 0.85 times
07 Wed Jan 2026 10.13 9.77 to 10.58 3.9% 0.91 times
06 Tue Jan 2026 9.75 9.31 to 10.17 4.06% 0.57 times

Videos related to: NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NTLA announcements Intellia Therapeutics, Inc. announcements and dividends declared USA

 

Back to top